Aug 12, 2020
IDEAYA Biosciences, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update
Aug 12, 2020
Innovent and Eli Lilly Announce Acceptance of a Supplemental New Drug Application of TYVYT® (Sintilimab Injection) in Combination with Gemcitabine and Platinum as First-Line Therapy in Squamous Non-Small Cell Lung Cancer in China
Aug 12, 2020
KAHR Medical Announces FDA Clearance of IND Application for DSP107, anti-CD47 Candidate for the Treatment of Solid Tumors
Aug 12, 2020
ClearCam Announces the Closing of its $2.6M Seed Series 2 Round of Funding
Aug 12, 2020
Global Food Allergen Testing Industry Report 2020-2024
Aug 12, 2020
Survey Finds Lack Of School Immunization Requirements Are Stopping Healthcare Providers From Vaccinating Adolescents Against Deadly Meningitis B
Aug 12, 2020
Yoga Shown to Improve Anxiety, Study Shows
Aug 12, 2020
Health Canada provides COVID-19 Interim Order approval for Bactiguard's endotracheal tubes
Aug 12, 2020
Resoundant Expands Its Research Services Footprint
Aug 12, 2020
QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma
Aug 12, 2020
Chemotherapy-induced Nausea & Vomiting Drugs Market, 2024 - Focus on Serotonin & NK1 Receptor Antagonists and Other Therapies
Aug 11, 2020
The first Virtual Microscope of the human brain, developed by Darmiyan, accurately measures Alzheimer's-related abnormalities
Aug 11, 2020
Cardiff Oncology Announces Second Quarter 2020 Results and Highlights
Aug 11, 2020
FSHD Society is funding the expansion of the FSHD Clinical Trial Research Network
Aug 11, 2020
Study Suggests Potential Role for Laser Ablation in Glioblastoma Treatment, Monteris Medical Announces
Aug 11, 2020
Aesculap, Inc. to Sponsor Virtual Symposium on Narcotic Reduction Strategies in Minimally Invasive Surgery
Jun 22, 2020
Dracen announces two DRP-104 presentations at AACR
Jun 22, 2020
Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity
Jun 22, 2020
FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX® (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
Jun 22, 2020
DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II